Takita M, Matsumoto S, Shimoda M, Chujo D, Itoh T, Iwahashi S, SoRelle J A, Onaca N, Naziruddin B, Levy M F
Baylor Research Institute, Islet Cell Laboratory, Dallas, Texas, USA.
Transplant Proc. 2011 Nov;43(9):3250-5. doi: 10.1016/j.transproceed.2011.10.029.
When patients do not become insulin independent after islet cell transplantation (ICT), another aim is to eliminate severe hypoglycemia. Previously we reported that a secretory unit of islet transplant objects (SUITO) index score >10 was associated with a reduction of severe hypoglycemia. In this study, we assessed patients' satisfaction with their insulin therapy based on the SUITO index.
The study involved 11 islet recipients with type 1 diabetes who underwent ICT but still used insulin. From those patients, 41 Insulin Therapy Satisfaction Questionnaires (ITSQ) were collected. The SUITO index (fasting C-peptide [ng/mL] × 1500/blood glucose [mg/dL] - 63) was calculated at the same outpatient visits that the survey was administered. ITSQ scores were summarized using subscales and compared among 3 groups: the pre-ICT group, the low-SUITO group (SUITO index score <10 post-ICT), and the high-SUITO group (SUITO index score ≥10). Higher survey scores indicated better satisfaction.
Significant trend relationships across the 3 groups were observed in the ITSQ total score (P = .02 with Jonckheere-Terpstra test) and subscale scores of glycemic control (P < .001), hypoglycemic control (P = .01), and inconvenience of regimen (P = .004). The pairwise comparisons between the 3 groups found significant differences: high SUITO versus both pre-ICT and low SUITO for the total ITSQ score (P = .03 and .005, respectively) and glycemic control score (P = .008 and .001, respectively), and high SUITO versus low SUITO for hypoglycemic control score (P = .04) and inconvenience of regimen score (P = .008).
Islet recipients with a SUITO index ≥10 experienced higher satisfaction with insulin injection therapy compared with the pre-ICT group, even though they were insulin dependent. A SUITO index ≥10 is a reasonable benchmark for successful ICT.
胰岛细胞移植(ICT)后患者若未实现胰岛素自主分泌,另一目标是消除严重低血糖。此前我们报道,胰岛移植对象分泌单位(SUITO)指数评分>10与严重低血糖的减少相关。在本研究中,我们基于SUITO指数评估了患者对胰岛素治疗的满意度。
本研究纳入了11例接受ICT但仍使用胰岛素的1型糖尿病胰岛移植受者。从这些患者中收集了41份胰岛素治疗满意度问卷(ITSQ)。在进行调查的同一门诊就诊时计算SUITO指数(空腹C肽[ng/mL]×1500/血糖[mg/dL]-63)。ITSQ评分使用分量表进行汇总,并在3组之间进行比较:ICT前组、低SUITO组(ICT后SUITO指数评分<10)和高SUITO组(SUITO指数评分≥10)。调查得分越高表明满意度越高。
在ITSQ总分(Jonckheere-Terpstra检验P = 0.02)以及血糖控制(P < 0.001)、低血糖控制(P = 0.01)和治疗方案不便性(P = 0.004)的分量表得分方面,观察到3组之间存在显著的趋势关系。3组之间的两两比较发现了显著差异:高SUITO组与ICT前组和低SUITO组相比,ITSQ总分(分别为P = 0.03和0.005)以及血糖控制得分(分别为P = 0.008和0.001)有显著差异,高SUITO组与低SUITO组相比,低血糖控制得分(P = 0.04)和治疗方案不便性得分(P = 0.008)有显著差异。
SUITO指数≥10的胰岛移植受者与ICT前组相比,对胰岛素注射治疗的满意度更高,尽管他们仍依赖胰岛素。SUITO指数≥10是ICT成功的合理基准。